fecal immunochemical test – UF Innovate https://innovate.research.ufl.edu Building business on innovation Tue, 12 Aug 2025 04:44:23 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://innovate.research.ufl.edu/wp-content/uploads/favicon-blue_1.png fecal immunochemical test – UF Innovate https://innovate.research.ufl.edu 32 32 DiaCarta Reports Positive Clinical Trial Data for Its Blood Based Test To Triage FIT-Positive Patients Enrolled in CRC Screening Programs https://innovate.research.ufl.edu/diacarta-reports-positive-clinical-trial-data/ Mon, 06 Jan 2025 00:00:00 +0000 https://scaddev1.com/diacarta-reports-positive-clinical-trial-data/ UF Innovate | Sid Martin Biotech alum DiaCarta Inc., a precision molecular diagnostic company, has announced the publication of its prospective clinical trial data on its blood-based test for triaging FIT (fecal immunochemical test)-positive patients in colorectal cancer (CRC) screening. The findings reveal that in triaging FIT-positive patients in CRC screening, the QuantiDNA™ test from patients’ plasma reduces the need for colonoscopy examinations by 33% and is non-inferior to the standard of care in detecting significant colorectal lesions.

Read more about DiaCarta Reports Positive Clinical Trial Data for Its Blood Based Test To Triage FIT-Positive Patients Enrolled in CRC Screening Programs. ]]>